Network Pharmacological Analysis of Yi-Guan Decoction on "Different Diseases with Same Treatment"
- VernacularTitle:一贯煎“异病同治”的网络药理学分析
- Author:
Mengdie YANG
1
;
Feifei CAI
;
Rong WU
;
Xiaole CHEN
;
Qiusha PAN
;
Yuanjia HU
;
Shibing SU
Author Information
- Keywords: Yi-Guan decoction; network pharmacology; different diseases with same treatment; mechanism
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(12):1912-1919
- CountryChina
- Language:Chinese
- Abstract: This study was aimed to predict active compounds,drug targets and potential diseases of Yi-Guan decoction (YGD) by network pharmacological technology,and to clarify molecular mechanisms of YGD efficiency on different diseases with liver and kidney yin deficiency syndrome (LKYDS).Chemistry compounds,targets and related diseases from YGD were collected from TCMSP,TCM Database@Taiwan,TCMID,HIT,Drugbank,PubChem and TTD databases.The YGD compounds-targets-diseases network was constructed.The network topology was analyzed by Cytoscape software.The analysis of GO biological processes and KEGG pathways enrichment were performed by DAVID website.The results showed that 849 chemical compounds were identified from Beishashen,Maidong,Danggui,Shengdihuang,Chuanlianzi and Gouqizi.There were 49 active CHM compounds that were both oral bioavailability (OB) ≥ 30％ and drug-likeness (DL) ≥ 0.18,corresponding to 200 target proteins and 264 diseases.The top three GO biological processes were response to organic substance,regulation of cell proliferation,and response to endogenous stimulus,respectively.The top three KEGG pathways were pathways in cancer,hepatitis B,and prostate cancer,respectively.It was concluded that the analysis on YGD was conducted based on network pharmacology,and the compound-target-disease network was built,which may help to clarify the mechanisms of YGD efficiency on different diseases with LKYDS.It can provide clues to find new potential clinical adaptation of disease and new drugs.
